Caroline D. Scatena - Concepedia

Author

Caroline D. Scatena

Vanderbilt University

Also Known As

C D Scatena, C. D. Scatena, Caroline D Scatena, Caroline D. Scatena

Publications

795

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Washington University in St. Louis

About

Caroline D. Scatena is an author at Vanderbilt University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	552
2	Cell Biology	6	6	505
3	Health Sciences	1	1	70
4	Cellular Physiology	1	1	230
5	Endocrinology	1	1	25

Caroline D. Scatena

Publications

783

Citations

H-Index

Page 1

	Year	Citations
Mitotic Phosphorylation of Bcl-2 during Normal Cell Cycle Progression and Taxol-induced Growth Arrest Caroline D. Scatena, Zoe A. Stewart, Deborah J. Mays, Journal of Biological Chemistry Chemoprevention StrategyApoptosisCell DeathCell ProliferationCell Cycle	1998	230
p53 Regulation of G <sub>2</sub> Checkpoint Is Retinoblastoma Protein Dependent Patricia M. Flatt, Luo Jia Tang, Caroline D. Scatena, Molecular and Cellular Biology	2000	161
p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest Patricia M. Flatt, Kornélia Polyák, Luo Jia Tang, Cancer Letters P53-dependent ExpressionDevelopmental BiologyReversible Growth ArrestMedicineCell Death	2000	89
Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. Steven D. Leach, Caroline D. Scatena, Christopher J. Keefer, PubMed ApoptosisCell DeathP53-mediated Growth ArrestCell ProliferationCell Cycle	1998	70
Imaging of bioluminescent LNCaP‐luc‐M6 Tumors: A new animal model for the study of metastatic human prostate cancer Caroline D. Scatena, Mischa A. Hepner, Yoko Oei, The Prostate	2004	70
A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. Sajid Khan Tahir, Edward K. Han, B Credo, PubMed Chemoprevention StrategyCytoskeletonTumor BiologyDrug ResistanceMicrotubule Inhibitors	2001	66
Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo Caroline D. Scatena, Jeffrey L. Kumer, Jennifer P. Arbitrario, Cancer Chemotherapy and Pharmacology Medicinal ChemistryFirst-in-class Anticancer QuinoloneMedicineMarrow AplasiaPharmacotherapy	2010	47
Characterization of a Human-Specific Regulator of Placental Corticotropin-Releasing Hormone Caroline D. Scatena, Stuart B. Adler Molecular Endocrinology GeneticsCrh PromoterTranscriptional RegulationSignaling PathwayChoriocarcinoma Cell Lines	1998	25
Trans-acting factors dictate the species-specific placental expression of corticotropin-releasing factor genes in choriocarcinoma cell lines. Caroline D. Scatena, Stuart B. Adler Endocrinology PathologyTrans-acting FactorsEmbryologyTumor BiologyTranscriptional Regulation	1996	25

Page 1